RAS Dialogue Blog
Join the discussion! Post comments, ask questions, and share information with RAS experts. Subscribe to receive notifications when a new RAS Dialogue article is posted.
-
The use of Molecular Docking as a ligand discovery tool; Can machine learning help the pursuit for ligands?
Molecular docking is a powerful computational tool used in drug discovery, and has been a valuable asset in the search for KRAS therapeutics. Will machine learning/AI drive it to new heights?
-
Could CryoEM structures of neurofibromin lead the way to better therapeutic approaches for Neurofibromatosis type 1?
Several structures have been recently reported detailing the NF1 protein. Will these structures help researchers discover novel therapeutic approaches to neurofibromatosis type 1?
-
Top-Down Proteomics Reveals the KRAS Proteoform Landscape in Colorectal Cancer
Measuring PTM differences across RAS isoforms and mutants is quite the challenge. Here, the authors discuss how they used top-down proteomics to uncover a diverse RAS proteoform landscape across cancer cell lines and tumor samples.
-
Sin1: a novel RAS effector with isoform specificity
Sin1, a member of the mTORC2 complex, is found to interact preferentially with KRAS4A via an atypical RAS binding domain. This interaction is shown to be dispensable for mTORC2 activity.
-
Simulating Ras: 30 years of progress
Progress in computational simulations of Ras’s movement within lipid bilayers reveal the membrane’s potential directive role on Ras orientation and signaling.